Correlation Between GM and DOD Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GM and DOD Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GM and DOD Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between General Motors and DOD Biotech Public, you can compare the effects of market volatilities on GM and DOD Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GM with a short position of DOD Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of GM and DOD Biotech.

Diversification Opportunities for GM and DOD Biotech

-0.36
  Correlation Coefficient

Very good diversification

The 3 months correlation between GM and DOD is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding General Motors and DOD Biotech Public in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on DOD Biotech Public and GM is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on General Motors are associated (or correlated) with DOD Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of DOD Biotech Public has no effect on the direction of GM i.e., GM and DOD Biotech go up and down completely randomly.

Pair Corralation between GM and DOD Biotech

Allowing for the 90-day total investment horizon General Motors is expected to generate 0.61 times more return on investment than DOD Biotech. However, General Motors is 1.65 times less risky than DOD Biotech. It trades about 0.08 of its potential returns per unit of risk. DOD Biotech Public is currently generating about 0.03 per unit of risk. If you would invest  4,803  in General Motors on September 5, 2024 and sell it today you would earn a total of  563.00  from holding General Motors or generate 11.72% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy96.88%
ValuesDaily Returns

General Motors  vs.  DOD Biotech Public

 Performance 
       Timeline  
General Motors 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in General Motors are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of very weak primary indicators, GM displayed solid returns over the last few months and may actually be approaching a breakup point.
DOD Biotech Public 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in DOD Biotech Public are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite quite conflicting fundamental indicators, DOD Biotech may actually be approaching a critical reversion point that can send shares even higher in January 2025.

GM and DOD Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GM and DOD Biotech

The main advantage of trading using opposite GM and DOD Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GM position performs unexpectedly, DOD Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DOD Biotech will offset losses from the drop in DOD Biotech's long position.
The idea behind General Motors and DOD Biotech Public pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Other Complementary Tools

Money Managers
Screen money managers from public funds and ETFs managed around the world
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes